Skip to main content
. 2024 May 31;73:102665. doi: 10.1016/j.eclinm.2024.102665

Table 2.

Equivalence test for primary outcomes.

T0 blood loss
log (T0 blood loss)
TOST
Mean 95% CI Mean 95% CI
Synthetic oxytocin (n = 127) 269.12 219.39–318.84 5.19 5.03–5.35 Test for difference
Tranexamic acid (n = 104) 263.88 215.25–312.52 5.19 5.02–5.37 H0: no difference (diff = 0)
p-value >0.05 (not rejected)
Overall (n = 231) 266.76 231.99–301.53 5.19 5.07–5.31
Test for equivalence
Difference 5.23 −64.81 to 75.28 0.00 −0.24 to 0.24 H0: no equivalence (|θ| ≥ Δ)
p-value <0.05 (rejected)
p-value for normality <0.001 (not normal) >0.05 (normal)
Equivalence limits (Δ) 150 mL 5.01 (log units) Conclusion: equivalence

T0 blood loss
log (T0 blood loss)
TOST
Mean 95% CI Mean 95% CI
Synthetic oxytocin (n = 119) 397.66 334.36–460.96 5.68 5.54–5.82 Test for difference
Tranexamic acid (n = 91) 405.64 344.23–467.04 5.75 5.59–5.90 H0: no difference (diff = 0)
p-value >0.05 (not rejected)
Overall (n = 210) 401.12 356.81–445.43 5.71 5.61–5.81
Test for equivalence
Difference −7.97 −97.61 to 81.66 −0.07 −0.27 to 0.14 H0: no equivalence (|θ| ≥ Δ)
p-value <0.05 (rejected)
p-value for normality <0.001 (not normal) >0.05 (normal)
Equivalence limits (Δ) 150 mL 5.01 (log units) Conclusion: equivalence